For Media: UK Press Releases
This page contains resources intended for journalists only. For media enquiries about our press releases please contact ukmediaenquiries@bayer.com
Chemicals Regulation Directorate lifts restriction for Bayer’s Iblon® fungicide and adds barley to approved crops
Bayer receives MHRA authorisation for new indication of Nubeqa® (darolutamide) plus androgen deprivation therapy as a treatment option in metastatic hormone-sensitive prostate cancer
Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in Phase III studies
Elinzanetant meets all primary and secondary endpoints in Phase III study OASIS 4 for treatment of moderate to severe vasomotor symptoms caused by breast cancer treatments
Bayer receives positive CHMP opinion for acoramidis for treatment of adults with transthyretin amyloid cardiomyopathy with UK MHRA submission underway